Lymphoma treatment cost in India typically runs from AUD $865 for chemotherapy to AUD $59,101 for complex bone marrow transplants. Initial diagnostics, such as a bone marrow biopsy, cost between AUD $1,009 and AUD $2,162. Total expenses depend on the lymphoma type, required cycles, and clinic choice. Patients from Australia often save 70–80% compared to local private healthcare costs. Top medical hubs include Bengaluru, Gurgaon, and Chennai.
Typical Lymphoma Treatment Costs in India
Bookimed Expert Insight: Patients requiring advanced stem cell procedures find high value in Gurgaon. Dr Rahul Bhargava has performed over 1,000 bone marrow transplants and established low-cost centres. For precision radiation, HCG Manavata Cancer Centre uses Halcyon and tomotherapy technology. Large networks like Manipal Hospitals serve over 2 million patients yearly, providing reliable infrastructure for complex chemotherapy protocols at scale.
| India | Thailand | Turkey | |
| Radiation therapy for colorectal cancer | from AUD $4,613 | from AUD $7,928 | from AUD $10,090 |
| Chemotherapy for breast cancer | from AUD $5,045 | from AUD $4,324 | from AUD $1,730 |
| Chemotherapy | from AUD $793 | from AUD $2,883 | from AUD $3,503 |
| CAR T-cell therapy | from AUD $72,074 | from AUD $360,370 | from AUD $216,222 |
| Bone marrow transplantation | from AUD $21,622 | from AUD $72,074 | from AUD $51,893 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma treatment journey.
Dr Prakash Pandit is a Consultant Radiation Oncologist at the HCG Manavata Cancer Centre. He leads treatment plans using high-precision radiation technologies to target tumours while sparing healthy tissue.
Professor Gaurav Kharya is a specialist in paediatric haematology and oncology who leads the blood and marrow transplant team at Artemis Hospital.
Dr Mallikarjun Kalashetty is a dedicated oncohematologist at Manipal Hospitals who specialises in bone marrow transplantation for complex blood cancers.
Indian oncology centres report an 83.6% 5-year survival rate for Hodgkin lymphoma. Non-Hodgkin lymphoma typically shows 60% to 80% survival at major facilities. Outcomes for early-stage cases frequently exceed 90%. Success matches global standards through protocols like CAR T-cell therapy.
Bookimed Expert Insight: Lymphoma success in India often depends on high-volume expertise and on-site transplant capabilities. Dr Rahul Bhargava at Fortis Gurgaon has performed 1,000+ transplants since 2010. Specialist centres like HCG Manavata Cancer Centre serve 75,000+ patients annually. High volumes allow Indian specialists to manage complex relapses that smaller clinics cannot handle.
Patient Consensus: Patients emphasise that success relies on accurate pathology reviews and PET-CT monitoring. They note that starting treatment at major tertiary centres in India prevents diagnostic delays and improves results.
India offers specialised therapies for refractory or relapsed lymphoma. These include indigenous CAR-T cell therapy, bone marrow transplants, and targeted biological agents. Specialists use intensive protocols like allogeneic stem cell transplantation and immunotherapy. They use these when standard chemotherapy fails. These treatments are available at NABH-accredited facilities.
Bookimed Expert Insight: India is becoming a global hub for cost-effective cellular therapies. Dr Rahul Bhargava at Fortis has overseen over 1,000 transplants. This high-volume expertise contributes to better outcomes. Indigenous CAR-T therapy is a breakthrough. However, complex cases often benefit from centres like Manipal Hospitals. They use IBM Watson for oncology to support treatment decisions.
India provides high-level lymphoma care through specialised tertiary centres and expert haemato-oncologists. Recognised facilities such as Manipal Hospitals and Fortis Memorial Research Institute offer biological therapies, bone marrow transplants, and CAR T-cell treatments. Dedicated specialists in Delhi, Bengaluru, and Chennai manage both Hodgkin and Non-Hodgkin lymphoma cases.
Bookimed Expert Insight: Lymphoma outcomes in India rely heavily on diagnostic precision rather than hospital size alone. Data shows that centres like HCG Manavata Cancer Centre integrate pathology and radiation experts into single teams. This allows doctors like Dr Girish Badarkhe to coordinate complex chemotherapy and transplant plans. Working under one roof reduces delays between diagnosis and treatment.
Patient Consensus: Patients recommend choosing large tertiary cancer hospitals with in-house PET-CT imaging and multidisciplinary tumour boards. Experience in India suggests requesting a second pathology read is vital. This confirms the specific lymphoma subtype before starting chemotherapy.
Lymphoma treatment in India commonly causes severe fatigue, nausea, and a high risk of infection. These effects require significant lifestyle changes, including strict diet adjustments and avoiding crowded public areas. Patients often manage symptoms through specialised diets and modified daily schedules at accredited centres like Manipal Hospitals.
Bookimed Expert Insight: Indian oncology centres often use intensive protocols. Specialists like Dr Rahul Bhargava have completed over 1,000 stem cell transplants. This high volume means clinic staff are well-versed in managing peak side effects. These effects typically occur a few days after each cycle ends.
Patient Consensus: Patients note that steroid-induced insomnia and mood swings can be disruptive. They are often as difficult as the chemotherapy itself. Patients emphasise the need for help with transport and chores. Simple tasks become exhausting during active treatment phases in India.
Lymphoma treatment stays in India vary from 2 days for initial chemotherapy to 3 months for transplants. International patients should plan for 1 to 2 weeks for diagnostics. Complex bone marrow transplants require 21 to 45 days of inpatient isolation after the pre-treatment workup.
Bookimed Expert Insight: Indian centres like HCG Manavata and Global Hospital Chennai manage high volumes, serving 80,000 patients annually. Senior specialists such as Dr Rahul Bhargava have performed over 1,000 transplants. This high volume often results in streamlined diagnostic phases. Patients rarely wait more than 48 hours for PET-CT results or biopsy reviews.
Patient Consensus: Patients note that initial diagnostic visits in India take 1 to 2 weeks for pathology confirmation. They recommend adding 10 days to any planned stay. This accounts for potential monitoring or low blood counts before long-haul flights.